• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CVS Health

Brooke Boyarsky Pratt left and Dr Angela Fitch Knownwell co-founders
Health Tech

HLTH25: knownwell lands $25M to scale hybrid obesity care

Knownwell picked up $25 million in fresh funding, riding the wave of investment in obesity care.
Heather Landi Oct 20, 2025 10:00am
Illustration of the concept of layoff and downsizing of staff

Fierce Healthcare Layoff Tracker—Stanford Children's cutting 87

Oct 15, 2025 12:00pm
Gilead
Favicon Fierce Pharma

CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo

Sep 19, 2025 11:22am
illustration of businessman man hand giving money to new business idea

Strive Health lands $550M capital raise at $1.8B valuation

Sep 9, 2025 7:05am
COVID vaccine

Pharmacies limit access to COVID shots in some states

Sep 2, 2025 7:30am
CVS Pharmacy logo is seen in Washington DC July 9 2024
Favicon Fierce Pharma

CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now

Aug 21, 2025 3:02pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings